pharmaphorum

JANUARY 18, 2024

Viral Vector Process Development & Manufacturing Summit Returns to Boston! Mike.Hammerton Thu, 18/01/2024 - 21:36 Bookmark this

Manufacturing 52

Manufacturing Development 52

pharmaphorum

DECEMBER 8, 2023

2nd mRNA Process Development & Manufacturing Summit Europe Mike.Hammerton Fri, 08/12/2023 - 14:08 Bookmark this

Manufacturing 52

Manufacturing Development 52

BioPharma Reporter

NOVEMBER 2, 2021

BioNet and Sartoriusâ BIA Separations are collaborating on production process development of mRNA vaccines: today announcing an optimized mRNA manufacturing process.

Manufacturing 98

Manufacturing Development Vaccination Vaccine 98

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development.

Development 311

Development Drugs Pharma Companies Life Science 311

pharmaphorum

MAY 9, 2023

2nd mRNA Process Development & Manufacturing Summit Mike.Hammerton Tue, 05/09/2023 - 09:49 Bookmark this

Manufacturing 52

Manufacturing Development 52

pharmaphorum

JUNE 2, 2023

2nd Process Development for Cell Therapies Mike.Hammerton Fri, 06/02/2023 - 10:15 Bookmark this

Development 52

Development 52

Pharma Times

JUNE 9, 2022

Agreement between the two companies includes process development of AAV-based gene therapies

Gene Therapy 104

Gene Therapy Gene Development Manufacturing 104

Bio Pharma Dive

APRIL 29, 2024

Consideration of sustainability early in process development, throughout the entire development cycle, and across the entire supply chain must also become common practice.

Manufacturing 269

Manufacturing Development 269

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. This will improve accessibility to services for AAV-mediated gene therapy programmes. This will improve accessibility to services for AAV-mediated gene therapy programmes.

Gene Therapy 256

Gene Therapy Gene Development Manufacturing 256

Pharmaceutical Technology

NOVEMBER 1, 2022

What is Research and Development (R&D)? This category includes organisations that have demonstrated a commitment to the research and development of new products and/or new processes. The category also includes companies that have made significant investments into their R&D processes. Is your company ranked?

Development 228

Development Research Production Vaccination 228

Drug Discovery World

APRIL 17, 2023

In the latest sponsored DDW Sitting Down With podcast Professor Ruth Roberts, Co-Founder ApconiX, and Claire Sadler, Project Toxicologist, discuss the benefits of carrying out a target safety assessment (TSA) during drug discovery and development whenever a biological target is going to be modulated.

Development 52

Development Drugs 52

BioPharma Reporter

MARCH 9, 2023

Arranta Bio, a Recipharm company, is doubling capacity at its Massachusetts facility for process development services supporting RNA therapeutics.

RNA 52

RNA Development Regulation Marketing 52

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. Optimise your cell therapy process: a guide to cell thawing. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.

Genetics 328

Genetics Medicine Development Gene Therapy 328

Drug Discovery World

OCTOBER 19, 2022

Yapan Bio has expanded its capabilities with a new process development facility at Genome Valley, Hyderabad, India, which has enhanced its ability to support end-to-end development and manufacturing of RNA, DNA and gene therapy products starting from plasmids. .

Development 52

Development Gene Therapy RNA DNA 52

Advarra

JANUARY 17, 2023

A highly valuable tool for research staff, electronic consent (eConsent) can simplify the consenting process for both staff and participants. When organizations begin to implement an eConsent platform , there are various things to consider to ensure a seamless implementation process. . Understand Organizational Requirements .

Development 52

Development Research Compliance Trials 52

Pharmaceutical Technology

MAY 24, 2023

Forge Biologics has joined the public-private collaboration, the Bespoke Gene Therapy Consortium (BGTC), to expedite the development and manufacture of new AAV [adeno-associated virus] gene therapies to treat patients with rare diseases. Shilling was appointed to represent the company on the steering committee of the BGTC.

Gene Therapy 242

Gene Therapy Gene Development Manufacturing 242

pharmaphorum

FEBRUARY 14, 2024

Discover how artificial intelligence (AI) is revolutionising the drug development process and transforming the way FDA-approved drugs are produced, ensuring compliance and optimising the supply chain. Learn more about the future of AI in pharmaceuticals.

Development 129

Development FDA Approval Drugs Compliance 129

Pharmaceutical Technology

APRIL 11, 2023

The US government is reportedly investing more than $5bn in a programme to accelerate the development of new Covid-19 vaccines and treatments. The programme is expected to develop long-lasting monoclonal antibodies and expedite the development of vaccines that produce mucosal immunity to reduce transmission and infection risks.

Vaccination 264

Vaccination Vaccine Development Antibody 264

Outsourcing Pharma

DECEMBER 15, 2022

Avid Bioservices has raised its full-year revenue guidance after process development sales hit a new high in its latest quarterly financial results.

Development 52

Development Sales Regulation Marketing 52

Pharmaceutical Technology

JUNE 1, 2023

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. It will focus on studying and developing new lipid nanoparticle (LNP) formulations for the delivery of RNA medicine.

Drug Delivery 242

Drug Delivery RNA Development Drugs 242

pharmaphorum

JULY 1, 2021

The clinical trial process is a long, expensive, complicated one that often ends in failure. This allows the FDA to receive, process, review and archive submissions efficiently. As part of a collaboration with the FDA, CDISC developed data standards to be used from study design and data collection through to analysis.

Development 72

Development Drugs Clinical Trials Clinical Trials 72

pharmaphorum

APRIL 26, 2024

Chemists at ETH Zurich have developed a new computer process that enables the generation of active pharmaceutical ingredients at speed, based on a protein’s three-dimensional surface.

Protein 105

Protein Development Drugs 105

Pharmaceutical Technology

FEBRUARY 16, 2023

The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. Under the deal, MD Anderson and Xilis aim to advance the development of drug and discovery projects using the MOS technology.

Development 242

Development Gene Therapy Gene Drugs 242

Pharmaceutical Technology

NOVEMBER 22, 2022

Umoja Biopharma has signed a research agreement with IASO Biotherapeutics (IASO Bio) to develop off-the-shelf therapies for haematological malignancies. The post Umoja and IASO partner to develop therapies for haematological malignancies appeared first on Pharmaceutical Technology.

Development 276

Development In-Vivo Engineer Clinical Trials 276

Pharmaceutical Technology

FEBRUARY 9, 2023

The collaboration is aimed at discovering and developing new advanced treatments for genitourinary (GU) tumours as well as other related serious diseases using ReviR’s RNA-targeted technologies. Its initial focus is to develop therapeutics in oncology, CNS, and genetically defined disease indications.

Development 241

Development RNA Gene Therapy Genetics 241

BioPharma Reporter

JULY 7, 2022

Turkey based Vaccizone has chosen Belgian CDMO, Exothera, to fast-track process development of its COVID-19 vaccine for European clinical trials.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

pharmaphorum

JANUARY 27, 2022

Embrace Technology Innovations to Optimise LNP Formulation, Alternative LNP Raw Materials, Process Control to Achieve Seamless Scale-Up, Compliance & Cost Effectiveness . With the overwhelming possibilities of lipid nanoparticles, there are key questions on formulation, process development and scalability that still need to be answered.

Development 52

Development Compliance Manufacturing Vaccination 52

Pharmaceutical Technology

JANUARY 17, 2023

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development.

Development 276

Development Gene Therapy Antibody Gene 276

Pharmaceutical Technology

APRIL 14, 2023

Twist Bioscience has introduced Twist T-cell receptor (TCR) and Twist chimeric antigen receptor (CAR) libraries to facilitate the development of cell therapies. Researchers will now be able to speed up the creation of tailor-made libraries that can help in identifying and developing new cell therapies.

Development 246

Development Gene Therapy Gene Antibody 246

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases. Optimise your cell therapy process: a guide to cell thawing.

Gene Therapy 237

Gene Therapy Gene Development Engineer 237

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies.

Vaccination 245

Vaccination Vaccine Development Allergies 245

Pharmaceutical Technology

MARCH 29, 2023

Regeneron Pharmaceuticals has collaborated with Sonoma Biotherapeutics to discover, develop and commercialise new regulatory T cell (Treg) therapies for autoimmune diseases. The two companies will together research and develop T cell therapies for Crohn’s disease and ulcerative colitis, as well as two other undisclosed indications.

Development 245

Development Gene Therapy Gene Production 245

Scienmag

JANUARY 26, 2021

Breakthrough could help researchers expand knowledge of bone biology A multidisciplinary team of researchers at the University of Massachusetts Amherst’s Institute for Applied Life Sciences (IALS) have developed a technique to replicate bone tissue complexity and bone remodeling processes.

Development 65

Development Research Life Science Engineer 65

pharmaphorum

OCTOBER 19, 2023

Innovative biopharma including BioNTech, Genentech, AskBio, Pfizer, Roche, Sanofi and more will unite in Boston

DNA 52

DNA Manufacturing Development 52

Pharmaceutical Technology

DECEMBER 12, 2022

Gilead company Kite has entered an international strategic partnership with Arcellx for the joint development and commercialisation of the latter’s T-cell therapy, CART-ddBCMA, to treat relapsed or refractory multiple myeloma patients. Optimise your cell therapy process: a guide to cell thawing.

Development 264

Development Gene Therapy Clinical Trials Clinical Trials 264

Pharma Tutor

JULY 13, 2022

A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS. Read more about A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS Log in or register to post comments About Authors. Sayyed , Ms. Review Articles.

Development 59

Development Drugs Pharmacy 59

Pharmaceutical Technology

JUNE 15, 2023

AI for drug development is rapidly streamlining R&D processes, speeding up time to market and providing a better experience for patients and providers. Learn more about the role of AI in drug development and how healthcare researchers are using it to shake up the field.

Development 130

Development Drugs Clinical Trials Clinical Trials 130